Business Context and Reporting Period
This Form 8-K Current Report was filed by iRhythm Technologies, Inc. on April 9, 2018. The filing reports a corporate governance event: the expansion of the Board of Directors and the appointment of a new director.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from seven to eight members.
- New Appointment: C. Noel Bairey Merz was appointed as a Class II director, effective immediately.
- Committee Assignment: Dr. Bairey Merz was appointed to the Compensation Committee.
- Compensation Award: Dr. Bairey Merz received an award of 3,120 restricted stock units (RSUs) vesting over three years.
Outlook, Risks, and Management Commentary
Management highlighted Dr. Bairey Merz's extensive background, including her roles as Medical Director at Cedars-Sinai Medical Center and Professor of Medicine at UCLA. The appointment is intended to leverage her expertise in cardiology and her experience with nonprofit boards and guideline panels. No specific financial guidance, risks, or contingencies were disclosed in this filing.
Key Facts for Investor Verification
- Verify the vesting schedule and terms of the 3,120 RSUs granted to Dr. Bairey Merz under the 2016 Equity Incentive Plan.
- Confirm the date of the 2018 Annual Meeting of Stockholders where Dr. Bairey Merz will stand for election.
- Review the Company's Definitive Proxy Statement (filed April 27, 2017) for details on the standard director compensation program applicable to Dr. Bairey Merz.
- Check the attached Press Release (Exhibit 99.1) for additional public commentary on the appointment.